CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Ipsen - IPN CFD

    104.17
    1.56%
    0.46
    Low: 102.67
    High: 104.47
    Market Trading Hours* (UTC) Opens on Friday at 08:00

    Mon - Fri: 08:00 - 16:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.46
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.022079 %
    Charges from full value of position ($-4.20)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.022079%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000143 %
    Charges from full value of position ($-0.03)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000143%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 5%
    Stock exchange France
    Commission on trade 0%

    *Information provided by Capital.com

    Ipsen SA ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 102.57
    Open* 102.67
    1-Year Change* -6.2%
    Day's Range* 102.67 - 104.47
    52 wk Range 94.85-130.70
    Average Volume (10 days) 80.02K
    Average Volume (3 months) 1.61M
    Market Cap 8.76B
    P/E Ratio 21.34
    Shares Outstanding 82.64M
    Revenue 3.28B
    EPS 4.90
    Dividend (Yield %) 1.14833
    Beta 0.58
    Next Earnings Date Feb 7, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 29, 2023 102.57 0.30 0.29% 102.27 103.57 102.07
    Nov 28, 2023 102.57 0.00 0.00% 102.57 102.87 101.57
    Nov 27, 2023 103.17 0.10 0.10% 103.07 104.67 102.87
    Nov 24, 2023 104.37 -0.10 -0.10% 104.47 105.17 103.67
    Nov 23, 2023 104.37 1.00 0.97% 103.37 104.67 102.97
    Nov 22, 2023 103.67 -0.10 -0.10% 103.77 104.27 103.17
    Nov 21, 2023 104.07 0.30 0.29% 103.77 104.17 102.07
    Nov 20, 2023 104.17 2.00 1.96% 102.17 104.77 101.37
    Nov 17, 2023 106.77 1.70 1.62% 105.07 107.17 104.77
    Nov 16, 2023 104.87 2.20 2.14% 102.67 105.17 102.67
    Nov 15, 2023 102.57 -2.70 -2.56% 105.27 105.47 102.07
    Nov 14, 2023 104.87 -0.90 -0.85% 105.77 105.97 104.37
    Nov 13, 2023 105.77 1.30 1.24% 104.47 105.77 104.37
    Nov 10, 2023 104.27 -2.00 -1.88% 106.27 107.87 103.77
    Nov 9, 2023 107.67 1.00 0.94% 106.67 108.47 106.17
    Nov 8, 2023 107.77 -0.30 -0.28% 108.07 109.36 106.57
    Nov 7, 2023 108.86 -1.60 -1.45% 110.46 110.76 108.36
    Nov 6, 2023 110.36 0.70 0.64% 109.66 111.16 108.76
    Nov 3, 2023 109.76 -1.00 -0.90% 110.76 111.86 109.76
    Nov 2, 2023 111.46 -0.70 -0.62% 112.16 113.76 111.26

    Ipsen Events

    Time (UTC) Country Event
    Thursday, December 7, 2023

    Time (UTC)

    10:59

    Country

    FR

    Event

    Ipsen SA Capital Markets Day
    Ipsen SA Capital Markets Day

    Forecast

    -

    Previous

    -
    Wednesday, February 7, 2024

    Time (UTC)

    07:30

    Country

    FR

    Event

    Full Year 2023 Ipsen SA Earnings Release
    Full Year 2023 Ipsen SA Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 3156.4 2748.6 2686.2 2692.8 2348.4
    Revenue 3156.4 2748.6 2686.2 2692.8 2348.4
    Cost of Revenue, Total 527.7 438.6 490.6 488 454.2
    Gross Profit 2628.7 2310 2195.6 2204.8 1894.2
    Total Operating Expense 2423.9 1920.8 2157.6 2728.1 1829.1
    Selling/General/Admin. Expenses, Total 1039.2 916.3 971.8 1020 953.1
    Research & Development 445.3 424.4 405.6 388.8 302.1
    Unusual Expense (Income) 138.6 25.6 191.9 698.4 37
    Other Operating Expenses, Total 273.1 115.9 97.7 132.9 82.7
    Operating Income 732.5 827.8 528.6 -35.3 519.3
    Interest Income (Expense), Net Non-Operating -9.3 -22.7 -13.1 -32.6 -8.9
    Other, Net -17.3 -16 13.3 29.3 -16.4
    Net Income Before Taxes 705.9 789.1 528.8 -38.6 494
    Net Income After Taxes 593.6 630.8 546.6 -58.2 385.9
    Minority Interest 1.1 -0.1 -0.9 -0.5 0.4
    Equity In Affiliates -1.5 0.4 -1.5 3.7 1.1
    Net Income Before Extra. Items 593.2 631.1 544.2 -55 387.4
    Total Extraordinary Items 55.4 15.5 3.8 4.2 2
    Net Income 648.6 646.6 548 -50.8 389.4
    Total Adjustments to Net Income 0.1 0.1
    Income Available to Common Excl. Extra. Items 593.2 631.1 544.2 -54.9 387.5
    Income Available to Common Incl. Extra. Items 648.6 646.6 548 -50.7 389.5
    Diluted Net Income 648.994 646.861 548 -50.7 389.5
    Diluted Weighted Average Shares 83.0978 83.3584 83.4481 83.095 83.2265
    Diluted EPS Excluding Extraordinary Items 7.14332 7.57406 6.52142 -0.66069 4.65597
    Dividends per Share - Common Stock Primary Issue 1.2 1.2 1 1 1
    Diluted Normalized EPS 8.54588 7.81956 8.01618 4.80245 5.00326
    Dilution Adjustment 0.39417 0.26139
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total revenue 1623.1 1658.5 1497.9 1452.3 1414.6
    Revenue 1623.1 1658.5 1497.9 1452.3 1414.6
    Cost of Revenue, Total 269.9 285.6 242.1 235.1 250.6
    Gross Profit 1353.2 1372.9 1255.8 1217.2 1164
    Total Operating Expense 1327.5 1439.8 996.6 1027.3 1002.4
    Selling/General/Admin. Expenses, Total 552.7 551.9 487.3 488.2 483.4
    Research & Development 290.2 238.1 207.2 219.3 207.3
    Unusual Expense (Income) 29.5 137.5 3.7 23.5 4
    Other Operating Expenses, Total 185.2 226.7 56.3 61.2 57.1
    Operating Income 295.6 218.7 501.3 425 412.2
    Interest Income (Expense), Net Non-Operating -12 -9 -9.5 -10.5 -11.4
    Other, Net -22.1 4.9 -0.5 -13.9 0.1
    Net Income Before Taxes 261.5 214.6 491.3 400.6 400.9
    Net Income After Taxes 205.5 210.8 382.8 337.5 301.9
    Minority Interest 0.1 1.1 0 -0.8 -0.7
    Equity In Affiliates -10.3 -1 -0.5 0.3 0.1
    Net Income Before Extra. Items 195.3 210.9 382.3 337 301.3
    Total Extraordinary Items 0 43.3 12.1 5.5 1.2
    Net Income 195.3 254.2 394.4 342.5 302.5
    Total Adjustments to Net Income -0.1 0.1 -0.1 0.1 1.5
    Income Available to Common Excl. Extra. Items 195.2 211 382.2 337.1 302.8
    Income Available to Common Incl. Extra. Items 195.2 254.3 394.3 342.6 304
    Diluted Net Income 195.2 254.694 394.3 342.861 304
    Diluted Weighted Average Shares 83.0638 83.01 83.1857 82.9703 83.5165
    Diluted EPS Excluding Extraordinary Items 2.35 2.54661 4.59454 4.06605 3.62563
    Dividends per Share - Common Stock Primary Issue 0 1.2 0 1.2 0
    Diluted Normalized EPS 2.62909 4.17371 4.6292 4.30467 3.6617
    Dilution Adjustment 0.39417 0.26139
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 2397.6 1953.8 1578.8 1346.5 1185.6
    Cash and Short Term Investments 1200.3 826.4 691.4 412.6 350
    Cash 814.7 642.5 215.4 137.4
    Cash & Equivalents 1169.3 137.9 207.1
    Short Term Investments 31 11.7 48.9 59.3 5.5
    Total Receivables, Net 673.7 764.5 602.8 644 560.1
    Accounts Receivable - Trade, Net 632.5 564.3 476.2 565 463
    Total Inventory 284.1 219.4 213.9 214 198.5
    Prepaid Expenses 77.8 52.2 54.4
    Other Current Assets, Total 239.5 65.7 70.7 23.7 22.6
    Total Assets 5614.6 4990.5 4313 4306.9 3377.4
    Property/Plant/Equipment, Total - Net 581.4 647.5 646.6 679.3 474.5
    Property/Plant/Equipment, Total - Gross 1058.7 1290 1196.5 1170.7 934.5
    Accumulated Depreciation, Total -477.3 -642.5 -549.9 -491.4 -460
    Goodwill, Net 579.9 623.2 592.8 632.6 395.6
    Intangibles, Net 1585.4 1370 1121.1 1383.2 1011.9
    Long Term Investments 136.3 133.2 126.7 111.4 173.6
    Other Long Term Assets, Total 334 262.8 247 153.9 136.2
    Total Current Liabilities 1335.4 1228.4 1213.1 1452.5 959.2
    Accounts Payable 647.1 594.7 495.2 508.5 379.8
    Accrued Expenses 254.2 200.5 206.9 185.4
    Notes Payable/Short Term Debt 3.8 5.5 2.8 14.3 33.6
    Current Port. of LT Debt/Capital Leases 27.7 29.8 228.9 302.6 4.1
    Other Current Liabilities, Total 656.8 344.2 285.7 420.2 356.3
    Total Liabilities 2270.6 2255.3 2181.9 2555.8 1536.3
    Total Long Term Debt 663.8 657.8 639.1 696.3 297.9
    Long Term Debt 581.8 562.8 542.7 568.2 297.9
    Deferred Income Tax 77.9 101.8 79.9 107.7 19.7
    Minority Interest -0.6 2.5 2.7 2 2.3
    Other Liabilities, Total 194.1 264.8 247.1 297.3 257.2
    Total Equity 3344 2735.2 2131.1 1751.1 1841.1
    Common Stock 83.8 83.8 83.8 83.8 83.8
    Additional Paid-In Capital 122.3 122.3 122.3 741.9 741.7
    Retained Earnings (Accumulated Deficit) 3193.5 2635.9 2121.1 973.3 1105.6
    Treasury Stock - Common -107.2 -123.1 -102.1 -72.5 -63.3
    Other Equity, Total 51.6 16.3 -94 24.6 -26.7
    Total Liabilities & Shareholders’ Equity 5614.6 4990.5 4313 4306.9 3377.4
    Total Common Shares Outstanding 82.6392 82.497 82.7225 83.0373 83.0651
    Capital Lease Obligations 82 95 96.4 128.1
    Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Total Current Assets 1759.8 2397.6 2589 1953.8 1764.2
    Cash and Short Term Investments 438.1 1200.3 1123.2 826.4 739.6
    Cash & Equivalents 413.4 1169.3 1068.3 814.7 737.5
    Short Term Investments 24.7 31 54.9 11.7 2.1
    Total Receivables, Net 685.6 673.7 716.1 687.1 646.3
    Accounts Receivable - Trade, Net 649.4 632.5 623.8 564.3 554.6
    Total Inventory 350 284.1 190.1 219.4 232.7
    Other Current Assets, Total 286.1 239.5 559.6 220.9 145.6
    Total Assets 6090.6 5614.6 5507.1 4990.5 4521.5
    Property/Plant/Equipment, Total - Net 571.6 581.4 585.9 647.5 645.7
    Property/Plant/Equipment, Total - Gross 1089.6 1058.7 1088.2 1290 1239.3
    Accumulated Depreciation, Total -518 -477.3 -502.4 -642.5 -593.6
    Goodwill, Net 681 579.9 557.4 623.2 604.4
    Intangibles, Net 2547.9 1585.4 1373.1 1370 1142.4
    Long Term Investments 111.8 136.3 118.7 133.2 128.8
    Other Long Term Assets, Total 418.5 334 283 262.8 236
    Total Current Liabilities 1709.8 1335.4 1374.2 1228.4 1117
    Accounts Payable 746.6 647.1 577.8 594.7 518.6
    Notes Payable/Short Term Debt 1.2 3.8 30.6 5.5 11.5
    Current Port. of LT Debt/Capital Leases 178.1 27.7 29.3 29.8 180.4
    Other Current Liabilities, Total 783.9 656.8 736.5 598.4 406.5
    Total Liabilities 2686.3 2270.6 2442.6 2255.3 2134.9
    Total Long Term Debt 345.4 663.8 671.8 657.8 640.8
    Long Term Debt 274.7 581.8 584.3 562.8 550.2
    Capital Lease Obligations 70.7 82 87.5 95 90.6
    Deferred Income Tax 297.6 77.9 120.7 101.8 92.1
    Minority Interest -1 -0.6 1.6 2.5 1.7
    Other Liabilities, Total 334.5 194.1 274.3 264.8 283.3
    Total Equity 3404.3 3344 3064.5 2735.2 2386.6
    Common Stock 83.8 83.8 83.8 83.8 83.8
    Additional Paid-In Capital 122.3 122.3 122.3 122.3 122.3
    Retained Earnings (Accumulated Deficit) 3265.1 3193.5 2896.3 2635.9 282
    Treasury Stock - Common -86.1 -107.2 -102.3 -123.1 -100.5
    Other Equity, Total 19.2 51.6 64.4 16.3 1999
    Total Liabilities & Shareholders’ Equity 6090.6 5614.6 5507.1 4990.5 4521.5
    Total Common Shares Outstanding 82.6392 82.6392 82.497 82.497 82.7225
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 647.5 646.7 548.9 -50.2 389.1
    Cash From Operating Activities 973.3 917.4 771.3 627.7 570.9
    Cash From Operating Activities 336.5 246.4 234.7 161.2 142.6
    Deferred Taxes -136.3 -130.6 19.2
    Non-Cash Items 159.2 219.7 134 626.9 22.8
    Changes in Working Capital -169.9 -195.4 -10 20.4 -2.8
    Cash From Investing Activities -458.6 -332 -163.7 -1157.3 -274.3
    Capital Expenditures -252.9 -417.9 -140.7 -280.6 -287.5
    Other Investing Cash Flow Items, Total -205.7 85.9 -23 -876.7 13.2
    Cash From Financing Activities -164.2 -421.8 -307.5 550 -202.2
    Financing Cash Flow Items -19.1 -22.6 -3.9 6.5 -1.2
    Total Cash Dividends Paid -99.3 -82.9 -83.2 -83.2 -83
    Issuance (Retirement) of Stock, Net -11.3 -36.7 -36.4 -16.7 -7.7
    Issuance (Retirement) of Debt, Net -34.5 -279.6 -184 643.4 -110.3
    Foreign Exchange Effects 5.9 5.8 0.5 7.7 7.3
    Net Change in Cash 356.4 169.4 300.6 28.1 101.7
    Cash Taxes Paid 130.7 181.1
    Cash Interest Paid 18.2 21.5
    Dec 2022 Jun 2022 Dec 2021 Jun 2021
    Net income/Starting Line 647.5 394.3 646.7 303.3
    Cash From Operating Activities 973.3 334.3 917.4 357.2
    Cash From Operating Activities 336.5 105.8 246.4 110.3
    Deferred Taxes 5.6 31.1
    Non-Cash Items 159.2 -107.4 219.7 10.2
    Changes in Working Capital -169.9 -64 -195.4 -97.7
    Cash From Investing Activities -458.6 -178.6 -332 -77.6
    Capital Expenditures -252.9 -117.9 -417.9 -78.6
    Other Investing Cash Flow Items, Total -205.7 -60.7 85.9 1
    Cash From Financing Activities -164.2 40.9 -421.8 -194.6
    Financing Cash Flow Items -19.1 -3.3 -22.6 -2.9
    Total Cash Dividends Paid -99.3 -99.3 -82.9 -82.9
    Issuance (Retirement) of Stock, Net -11.3 -6.5 -36.7 -5.8
    Issuance (Retirement) of Debt, Net -34.5 150 -279.6 -103
    Foreign Exchange Effects 5.9 31.9 5.8 1.4
    Net Change in Cash 356.4 228.5 169.4 86.4
    Cash Taxes Paid 130.7 181.1
    Cash Interest Paid 18.2 21.5
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Mayroy SA Corporation 56.6223 47457736 0 2022-12-31 LOW
    Parvus Asset Management Europe Limited Investment Advisor/Hedge Fund 5.056 4237680 47337 2023-04-27 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1881 995780 748 2023-09-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0031 840782 20066 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.9999 838089 -3321 2023-09-30 LOW
    Oddo BHF Asset Management S.A.S Investment Advisor/Hedge Fund 0.998 836459 55248 2023-09-30 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.5822 487971 -2828 2023-09-30 LOW
    Black Creek Investment Management, Inc. Investment Advisor 0.3742 313611 -25493 2023-06-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.3711 311058 3005 2023-09-30 LOW
    Liontrust Investment Partners LLP Investment Advisor 0.3711 311011 13076 2023-08-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3216 269542 7 2023-09-30 LOW
    Ipsen S.A. Employees Corporation 0.2802 234860 -38994 2022-12-31 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.2321 194517 2096 2023-09-30 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.2172 182043 0 2023-08-31 LOW
    Goldman Sachs Asset Management, L.P. Investment Advisor 0.2142 179541 342 2023-09-30 LOW
    Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.2103 176249 0 2023-09-30 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.202 169285 3005 2023-09-30 LOW
    M&G Investment Management Ltd. Investment Advisor 0.1908 159882 -12698 2023-07-31 LOW
    CPP Investment Board Pension Fund 0.1873 157000 157000 2023-03-31 LOW
    Florida State Board of Administration Pension Fund 0.184 154185 65455 2022-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Ipsen Company profile

    Founded in 1929, Ipsen (IPN) is a leading international biopharmaceutical group, focusing on specialty care. The company develops and produces innovative medicines in 3 major areas: rare diseases, neurosciences and oncology. Ipsen also runs a consumer healthcare business. In general, the company sells over 20 drugs in more than 115 countries worldwide. Ipsen's R&D is focused on its differentiated and innovative technological platforms in the leading biotechnological hubs, based in Cambridge, the US, Oxford, the UK, and Paris-Saclay, France. Headquartered in Paris, the company employs 5,100 specialists. Included to the CAC Mid 60 index, the Ipsen share price (IPN) is set and traded on the Euronext Paris exchange.
    Industry: Pharmaceuticals (NEC)

    65 Quai Georges Gorse
    BOULOGNE-BILLANCOURT
    ILE-DE-FRANCE 92100
    FR

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    Gold

    2,040.70 Price
    -0.170% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    XRP/USD

    0.61 Price
    -1.170% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    15,850.00 Price
    -0.850% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    37,721.00 Price
    -0.170% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading